Compare Crown Castle International Corp (CCI) vs Canopy Growth Corp (CGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crown Castle International Corp vs Canopy Growth Corp — how do they compare? Crown Castle International Corp trades at $73.39 (market cap $31.33B), while Canopy Growth Corp trades at $1 (market cap $421.10M). The key difference: Crown Castle International Corp is far larger — about 74.4× Canopy Growth Corp's market cap, and Crown Castle International Corp pays a 5.77% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CCI | CGC | |
|---|---|---|
Market Cap | $31.33B | $421.10M |
Sector | Real Estate | Health |
52-Week High | $103.79 | $1.92 |
52-Week Low | $73.61 | $0.86 |
Enterprise Value | $53.69B | $378.55M |
Dividend Yield | 5.77% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crown Castle International Corp
Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.
Read more on CCI →About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →
